ぜんそく：疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
2.3 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.2.1 Family history of asthma is a strong predictor for asthma in children and adults 12
3.2.2 Puberty alters the risk for asthma in boys and girls 13
3.2.3 Maternal smoking during pregnancy greatly increases the risk of childhood asthma 14
3.2.4 Allergens are well-known asthma triggers 15
3.2.5 Common workplace exposures account for up to 11% of asthma cases in adults 16
3.2.6 Urban living conditions, not race, increase the risk of asthma by almost 50% 17
3.2.7 Obesity almost triples the risk of developing asthma 18
3.2.8 Asthmatics are 90% more likely to develop GERD 19
3.2.9 85% of asthmatics have allergic rhinitis 20
3.2.10 Panic disorders are common in asthmatics and severely impact disease control 21
3.2.11 39% of asthmatics are likely to develop depression 22
3.3 Global Trends 22
3.3.1 US 23
3.3.2 France 25
3.3.3 Germany 26
3.3.4 Italy 27
3.3.5 Spain 27
3.3.6 UK 28
3.3.7 Japan 30
3.3.8 Australia 30
3.3.9 China 31
3.3.10 India 32
3.4 Forecast Methodology 33
3.4.1 Sources Used 34
3.4.2 Forecast Assumptions and Methods 46
3.4.3 Sources Not Used 54
3.5 Epidemiology Forecast for Asthma (2013-2023) 55
3.5.1 Lifetime Prevalent Cases of Asthma 55
3.5.2 Age-Specific Lifetime Prevalent Cases of Asthma 57
3.5.3 Sex-Specific Lifetime Prevalent Cases of Asthma 59
3.5.4 Age-Standardized Lifetime Prevalence of Asthma 61
3.5.5 Distribution of Lifetime Prevalent Cases of Asthma by Severity 63
3.6 Discussion 65
3.6.1 Conclusions on Epidemiology Trends 65
3.6.2 Limitations of the Analysis 67
3.6.3 Strengths of the Analysis 68
4 Appendix 70
4.1 Bibliography 70
4.2 About the Authors 82
4.2.1 Epidemiologists 82
4.2.2 Reviewers 82
4.2.3 Acting Director of Epidemiology 83
4.2.4 Global Head of Healthcare 84
4.3 About GlobalData 85
4.4 About EpiCast 85
4.5 Disclaimer 86